China NMPA Inspection - Wuhan Runhe Biomedical Co., Ltd. - January 02, 2020
China NMPA unannounced inspection for Wuhan Runhe Biomedical Co., Ltd. published January 02, 2020. The National Medical Products Administration (NMPA) in China, operating under its regulatory framework for drug administration, issued a formal notifi
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA unannounced inspection for Wuhan Runhe Biomedical Co., Ltd. published January 02, 2020. The National Medical Products Administration (NMPA) in China, operating under its regulatory framework for drug administration, issued a formal notifi
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
Unknown Date
Product Type
Biologics
ID: 07292076-efcf-4c4f-8fdf-69ee7fb2b3e3
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox